SCHEMBL7367243

SCHEMBL7367243

NC(C(=O)c1nnc(CCCCN[C@@H]2N=CCN2)s1)C(NS(=O)(=O)c1cccc2ccccc12)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 4/20 0.47
SLC1A2 P43004 4/20 0.47
SLC1A1 P43005 4/20 0.47
ITGB3 P05106 5/20 0.33
ITGA2B P08514 4/20 0.33
ITGAV P06756 4/20 0.33
F2 P00734 2/20 0.32
SCN1A P35498 2/20 0.32
SCN2A Q99250 2/20 0.32
SCN3A Q9NY46 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MMP1 P03956 1/20 0.31
MMP2 P08253 1/20 0.31
MMP9 P14780 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8168330 0.85 ITGAV (0.44) SLC1A3SLC1A2SLC1A1ITGB3ITGA2B
SCHEMBL7366853 0.82 SLC1A3 (0.34) SLC1A3SLC1A2SLC1A1ITGB3ITGA2B
SCHEMBL7374456 0.80 SLC1A3 (0.51) SLC1A3SLC1A2SLC1A1ITGB3ITGA2B
SCHEMBL7373306 0.78 GLS (0.39) ITGB3ITGA2BITGAVF2
SCHEMBL7366550 0.77 SLC1A2 (0.41) SLC1A3SLC1A2SLC1A1
SCHEMBL8176077 0.67 ITGAV (0.46) ITGB3ITGA2BITGAV
SCHEMBL8168332 0.66 ITGB3 (0.56) ITGB3ITGA2BITGAVF2
SCHEMBL8177321 0.66 ITGB3 (0.42) ITGB3ITGA2BITGAV
SCHEMBL8179647 0.65 ITGAV (0.63) ITGB3ITGA2BITGAV
SCHEMBL8179651 0.65 ITGAV (0.63) ITGB3ITGA2BITGAV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1049693-A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS $g(a) v?$g(b) 3? ANTAGONISTS Du Pont Pharmaceuticals Company (US) 2000-11-08 EP claimed
WO-1999026945-A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS αvβ3 ANTAGONISTS DU PONT PHARMACEUTICALS COMPANY (US) 1999-06-03 WO claimed
EP-1049693-A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS $g(a) v?$g(b) 3? ANTAGONISTS Du Pont Pharmaceuticals Company (US) 2000-11-08 EP disclosed
WO-1999026945-A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS αvβ3 ANTAGONISTS DU PONT PHARMACEUTICALS COMPANY (US) 1999-06-03 WO disclosed